Vaccination information, motivations, and barriers in the context of meningococcal serogroup A conjugate vaccine introduction: A qualitative assessment among caregivers in Burkina Faso, 2018. Issue 43 (15th October 2021)

• Record Type: Journal Article
• Authors: Aksnes, Brooke Noel; Walldorf, Jenny A.; Nkwenkeu, Sylvain F.; Zoma, Robert L.; Mirza, Imran; Tarbangdo, Felix; Fall, Soukeynatou; Hien, Sansan; Ky, Cesaire; Kambou, Ludovic; Diallo, Alpha Oumar; Aké, Flavien H.; Hatcher, Cynthia; Patel, Jaymin C.; Novak, Ryan T.; Hyde, Terri B.; Medah, Isaïe; Soeters, Heidi M.; Jalloh, Mohamed F.
• Is Part Of: Vaccine. Volume 39:Issue 43(2021)
• Page Start: 6370
• Page End: 6377
• Publication Date: 2021-10-15
• Subjects: Burkina Faso -- Meningococcal serogroup A conjugate vaccine -- Measles vaccine -- Immunization schedule -- Vaccine introduction -- Vaccination challenges; Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2021.09.038
• Languages: English
• ISSNs: 0264-410X

Abstract

Highlights: Caregivers were motivated to vaccinate their children against measles and meningitis. Motivations were driven by vaccine communication and perceived disease protection. Health workers were trusted sources of vaccine information. Barriers included vaccine unavailability, knowledge gaps, and practical constraints. Vaccine uptake could be enhanced by using trusted messengers and addressing barriers. Abstract: Background: In March 2017, Burkina Faso introduced meningococcal serogroup A conjugate vaccine (MACV) into the Expanded Programme on Immunization. MACV is administered to children aged 15–18 months, concomitantly with the second dose of measles-containing vaccine (MCV2). One year after MACV introduction, we assessed the sources and content of immunization information available to caregivers and explored motivations and barriers that influence their decision to seek MACV for their children. Methods: Twenty-four focus group discussions (FGDs) were conducted with caregivers of children eligible for MACV and MCV2. Data collection occurred in February–March 2018 in four purposively selected districts, each from a separate geographic region; within each district, caregivers were stratified into groups based on whether their children were unvaccinated or vaccinated with MACV. FGDs were recorded and transcribed. Transcripts were coded and analyzed using qualitative content analysis. Results: We identified many different sources and content of information about MACV and MCV2 available to caregivers. Healthcare workers were most commonly cited as the main sources of information; caregivers also received information from other caregivers in the community. Caregivers' motivations to seek MACV for their children were driven by personal awareness, engagements with trusted messengers, and perceived protective benefits of MACV against meningitis. Barriers to MACV and MCV2 uptake were linked to the unavailability of vaccines, immunization personnel not providing doses, knowledge gaps about the 15–18 month visit, practical constraints, past negative experiences, sociocultural influences, and misinformation, including misunderstanding about the need for MCV2. Conclusions: MACV and MCV2 uptake may be enhanced by addressing vaccination barriers and effectively communicating vaccination information and benefits through trusted messengers such as healthcare workers and other caregivers in the community. Educating healthcare workers to avoid withholding vaccines, likely due to fear of wastage, may help reduce missed opportunities for vaccination.